Hans Erikssønn Fjøsne
Bakgrunn og aktiviteter
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
- (2018) Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment. British Journal of Cancer. vol. 119 (9).
- (2017) Interactions between the tumor and the blood systemic response of breast cancer patients. PLoS Computational Biology. vol. 13 (9:e1005680).
- (2017) Support vector machine for breast cancer classification using diffusion-weighted MRI histogram features: Preliminary study. Journal of Magnetic Resonance Imaging.
- (2016) A simplified approach to measure the effect of the microvasculature in diffusion-weighted MR imaging applied to breast tumors: Preliminary results. Radiology. vol. 281 (2).
- (2016) Diffusion weighted imaging for the differentiation of breast tumors: From apparent diffusion coefficient to high order diffusion tensor imaging. Journal of Magnetic Resonance Imaging. vol. 43 (5).
- (2015) Peripheral blood cells inform on the presence of breast cancer: A population‐based case–control study. International Journal of Cancer. vol. 136 (3).
- (2015) Inhomogeneous static magnetic field-induced distortion correction applied to Diffusion Weighted MRI of the breast at 3 Tesla. Magnetic Resonance in Medicine. vol. 74 (4).
- (2014) Metabolic characterization of triple negative breast cancer. BMC Cancer. vol. 14.
- (2013) Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery. PLOS ONE. vol. 8 (4).
- (2013) Malignt melanom – diagnostikk, behandling og oppfølging i Norge. Tidsskrift for Den norske legeforening. vol. 133 (20).
- (2012) Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR in Biomedicine. vol. 25 (11).
- (2011) Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel. PLOS ONE. vol. 6 (4).
- (2011) Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials. Acta Oncologica. vol. 50 (7).
- (2010) Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. Journal of Proteome Research. vol. 9 (2).
- (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR in Biomedicine. vol. 23 (4).
- (2008) Adjuvant cyclic tamoxifen and megestrol acetate treatment in post-menopausal breast cancer patients – longterm follow-up. European Journal of Surgical Oncology. vol. 34 (1).
- (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Journal of the National Cancer Institute. vol. 100 (7).
- (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade and hormone status. Breast Cancer Research and Treatment. vol. 104.
- (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR in Biomedicine. vol. 19 (1).
- (2005) MR spectroscopy of breast cancer tissue used for tumor classification and lymph node prediction. Breast Cancer Research and Treatment. vol. 94.